Annual Retainer:An annual cash retainer of $80,000 paid in quarterly installments and restricted stock rights* with a grant date market value of $90,000Lead Director Fee:$20,000 paid in quarterly installmentsAudit and Ethics Committee Chair Retainer:$10,000 paid in quarterly installmentsCompensation and Human Resources Committee Chair Retainer:$10,000 paid in quarterly installmentsFinance Committee Chair Retainer:$7,500 paid in quarterly installmentsNominating and Governance Committee Chair Retainer:$7,500 paid in quarterly installmentsSupplemental Meeting Fees:$1,500 payable for and after each meeting of a particular committee or the full Board, as the case may be, attended by a committee member or non-employee director, respectively, in excess of eight committee or full Board meetings annually
EX-10.1 2 pnm12312016ex101.htm EXHIBIT 10.1 Exhibit
Exhibit 10.1
2017 Director Compensation Summary
Non-employee directors of PNM Resources, Inc. (the “Company”) receive their annual retainer in the form of cash and stock-based compensation as determined by the Company's Board of Directors (the “Board”). At the December 2016 Board meeting, the Board approved making the following changes to director compensation for 2017: increasing the annual cash retainer from $60,000 to $80,000, increasing the market value of the annual award of restricted stock rights from $75,000 to $90,000, and providing that meeting attendance fees are only payable for and after attending more than eight meetings per year of the full Board or a particular committee. In addition, the vesting period for restricted stock rights was reduced to one year. Thus, the 2017 annual retainer for non-employee directors is as follows:
Annual Retainer: | An annual cash retainer of $80,000 paid in quarterly installments and restricted stock rights* with a grant date market value of $90,000 | |
Lead Director Fee: | $20,000 paid in quarterly installments | |
Audit and Ethics Committee Chair Retainer: | $10,000 paid in quarterly installments | |
Compensation and Human Resources Committee Chair Retainer: | $10,000 paid in quarterly installments | |
Finance Committee Chair Retainer: | $7,500 paid in quarterly installments | |
Nominating and Governance Committee Chair Retainer: | $7,500 paid in quarterly installments | |
Supplemental Meeting Fees: | $1,500 –payable for and after each meeting of a particular committee or the full Board, as the case may be, attended by a committee member or non-employee director, respectively, in excess of eight committee or full Board meetings annually |
Directors are also reimbursed for any Board-related expenses, such as travel expenses incurred to attend Board and Board committee meetings and director educational programs. Further, directors are indemnified by the Company to the fullest extent permitted by law pursuant to the Company’s bylaws and indemnification agreements between the Company and each director.
* The amount of the annual award of restricted stock rights is determined by dividing $90,000 by the closing price of the Company’s stock on the New York Stock Exchange on the day of the grant. Restricted stock rights granted under the Company’s Performance Equity Plan on and after 2017 will vest on the first anniversary of the grant date. These awards are typically made at the annual meeting of directors, unless the meeting occurs during a black-out period for trading in the Company's securities as specified in the Company’s Insider Trading Policy. As set forth under the Company’s Equity Compensation Awards Policy, under those circumstances, the Board will either (a) schedule a special meeting after the expiration of the black-out period, (b) make awards pursuant to a unanimous written consent executed after the expiration of the black-out period, or (c) pre-approve the equity awards with an effective date after the expiration of the black-out period. The date of the awards is the date on which the Board approves the awards, unless (i) the approval date is a non-trading day, in which case the date is the immediately preceding trading date or (ii) in the case of pre-approval during a black-out period, in which case the grant date is the first trading date after the expiration of the black-out period.